New Key Statistics Module, Z-Score and F-Score
OTCPK:SARSF Key Ratios
| Market Cap $ M | 19.32 |
| Enterprise Value $ M | 35.01 |
| P/E(ttm) | 61.76 |
| PE Ratio without NRI | 61.76 |
| Forward PE Ratio | -- |
| Price/Book | 116.67 |
| Price/Sales | 1.98 |
| Price/Free Cash Flow | 37.50 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 17.00 |
| EPS (TTM) $ | -- |
| Beneish M-Score | -1.12 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 34.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 9.76 |
| EV-to-EBITDA | 6.96 |
| PEG | 1.81 |
| Shares Outstanding M | 683.45 |
| Net Margin (%) | 2.82 |
| Operating Margin % | 26.02 |
| Pre-tax Margin (%) | 2.70 |
| Quick Ratio | 0.41 |
| Current Ratio | 0.60 |
| ROA % (ttm) | 1.32 |
| ROE % (ttm) | 7.50 |
| ROIC % (ttm) | 14.01 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.12 |
SARSF Number of Guru Trades
SARSF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SARSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SARSF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Canada House Wellness Group Inc Insider Transactions
No Available Data
News about OTCPK:SARSF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers